# Portfolio Council 研究建议

- Run ID: `rrh-final-risk-veto-20260908`
- 终态: `SAFE_NO_TRADE`
- 动作: `NO_TRADE`
- 仅供建议: `true`
- Risk 状态: `REJECTED`

## Thesis

The authorized evidence establishes only a USD 100 close price and USD 1,000,000 TTM revenue; it does not support a company-quality, valuation, or downside-risk thesis.

## Counter Thesis

The single price and revenue observations cannot establish valuation reasonableness, liquidity, volatility, revenue durability, profitability, cash conversion, or balance-sheet resilience.

## Evidence IDs

- `ev-risk-price`
- `ev-risk-revenue`

## 失效与重评条件

- The USD 100 price fact is invalidated if fixture-market-primary corrects or supersedes the observation as of 2026-01-30T21:00:00Z.
- The USD 1,000,000 TTM revenue fact is invalidated if fixture-filing-primary corrects or supersedes the observation as of 2025-12-31T00:00:00Z.
- This no-trade conclusion is invalidated when new authorized, point-in-time evidence materially closes the identified valuation, profitability, cash-flow, liquidity, and business-quality gaps.
- 仅在满足 Risk Engine 可行边界后重新评估。

## NO_TRADE

- 原因码: `RISK_VETO`
- 说明: deterministic Risk Engine 否决了 CIO 草案。
